ResearcherTUM KlinikumActive in the last 2 years
Kaan Çifcibaşı
Matched on ORCID iD 0000-0003-0830-9777; OpenAlex author ID A5012498096, A5017756956. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 36
2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 2 papers
Papers 6
- Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancers. Co-author DOI 10.1016/j.xcrm.2025.102546↗
- The substance P/ Neurokinin-1 receptor signaling drives perineural invasion in pancreatic ductal adenocarcinoma (PDAC). Co-author DOI 10.3389/fcell.2026.1876023↗
- Pancreatic cancer cells survive in the neural niche during neoadjuvant therapy. Co-author DOI 10.1016/j.canlet.2025.217894↗
- Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses. Co-author DOI 10.1016/j.ccell.2025.09.003↗
- Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion. Co-author DOI 10.1172/jci166333↗
- Regulatory T Cells in Pancreatic Cancer: Of Mice and Men. Co-author DOI 10.3390/cancers14194582↗
Closest collaborators
The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- İhsan Ekin Demir · 6 shared papers, 2022–2026 · strength 1.21
- Paper The substance P/ Neurokinin-1 receptor signaling drives perineural invasion in pancreatic ductal adenocarcinoma (PDAC). DOI 10.3389/fcell.2026.1876023↗
- Paper Pancreatic cancer cells survive in the neural niche during neoadjuvant therapy. DOI 10.1016/j.canlet.2025.217894↗
- Paper Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinst… DOI 10.1016/j.xcrm.2025.102546↗
- Carmen Mota Reyes · 5 shared papers, 2022–2026 · strength 0.91
- Paper Pancreatic cancer cells survive in the neural niche during neoadjuvant therapy. DOI 10.1016/j.canlet.2025.217894↗
- Paper Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinst… DOI 10.1016/j.xcrm.2025.102546↗
- Paper Regulatory T Cells in Pancreatic Cancer: Of Mice and Men. DOI 10.3390/cancers14194582↗
- Alexander Muckenhuber · 3 shared papers, 2023–2025 · strength 0.52
- Paper Pancreatic cancer cells survive in the neural niche during neoadjuvant therapy. DOI 10.1016/j.canlet.2025.217894↗
- Paper Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses. DOI 10.1016/j.ccell.2025.09.003↗
- Paper Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion. DOI 10.1172/jci166333↗
- Guralp Onur Ceyhan · 3 shared papers, 2023–2025 · strength 0.52
- Paper Pancreatic cancer cells survive in the neural niche during neoadjuvant therapy. DOI 10.1016/j.canlet.2025.217894↗
- Paper Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses. DOI 10.1016/j.ccell.2025.09.003↗
- Paper Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion. DOI 10.1172/jci166333↗
- Achim Krüger · 3 shared papers, 2023–2026 · strength 0.49
- Paper Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinst… DOI 10.1016/j.xcrm.2025.102546↗
- Paper Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses. DOI 10.1016/j.ccell.2025.09.003↗
- Paper Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion. DOI 10.1172/jci166333↗
- Roland Rad · 3 shared papers, 2023–2026 · strength 0.49
- Paper Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinst… DOI 10.1016/j.xcrm.2025.102546↗
- Paper Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses. DOI 10.1016/j.ccell.2025.09.003↗
- Paper Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion. DOI 10.1172/jci166333↗
- Dieter Saur · 3 shared papers, 2023–2026 · strength 0.49
- Paper Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinst… DOI 10.1016/j.xcrm.2025.102546↗
- Paper Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses. DOI 10.1016/j.ccell.2025.09.003↗
- Paper Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion. DOI 10.1172/jci166333↗
- Helmut Friess · 2 shared papers, 2022–2025 · strength 0.42
- Stefanie Bärthel · 2 shared papers, 2023–2026 · strength 0.33
- Paper Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinst… DOI 10.1016/j.xcrm.2025.102546↗
- Paper Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion. DOI 10.1172/jci166333↗
- Katja Schiedlauske · 1 shared paper, 2026 · strength 0.30
- Alina Deipenbrock · 1 shared paper, 2026 · strength 0.30
- Dirk Weyhe · 1 shared paper, 2026 · strength 0.30
- Nicole Elisabeth Teusch · 1 shared paper, 2026 · strength 0.30
- Iréne Esposito · 1 shared paper, 2026 · strength 0.30
- Helmut Frieß · 2 shared papers, 2023–2025 · strength 0.28
- Lei Ren · 2 shared papers, 2023–2025 · strength 0.28
- Linhan Ye · 2 shared papers, 2023–2025 · strength 0.28
- Kıvanç Görgülü · 2 shared papers, 2023–2025 · strength 0.28
- Saliha Elif Yıldızhan · 2 shared papers, 2023–2025 · strength 0.28
- Roland Michael Schmid · 2 shared papers, 2023–2025 · strength 0.28
- Hana Algül · 2 shared papers, 2023–2025 · strength 0.28
- Rüdiger Göß · 1 shared paper, 2025 · strength 0.24
- Ilaria Pergolini · 1 shared paper, 2025 · strength 0.24
- Daniele Lucarelli · 1 shared paper, 2026 · strength 0.21
- Julian Frädrich · 1 shared paper, 2026 · strength 0.21
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.